Trend analysis: Climate biotech: carbon-negative processes — where the value pools are (and who captures them)

Engineered biological systems now remove carbon dioxide from the atmosphere at costs as low as $60 per ton in laboratory-validated pathways, compared to $400-600 per ton for leading direct air capture (DAC) technologies, according to a 2025 National Academies of Sciences analysis. That order-of-magnitude cost advantage, combined with $3.8 billion in venture capital deployed into climate biotech between 2022 and 2025, is reshaping the carbon removal landscape and creating value pools that will define the next generation of climate infrastructure companies.

Why It Matters

The global carbon removal market must scale from approximately 2 million tons of CO2 removed annually in 2025 to 6-10 gigatons per year by 2050 to meet Paris Agreement temperature targets, per the Intergovernmental Panel on Climate Change. Compliance-driven demand is accelerating: the EU Carbon Border Adjustment Mechanism (CBAM) entered its permanent phase in 2026, California's cap-and-trade program tightened its offset protocol to favor durable removal methods, and the US Department of Energy committed $3.5 billion to Regional Direct Air Capture Hubs under the Bipartisan Infrastructure Law. At the same time, voluntary corporate procurement has matured. Frontier (the advance market commitment backed by Stripe, Google, Meta, and McKinsey) has contracted over $1 billion in carbon removal purchases, with biological removal pathways securing a growing share of those commitments.

Climate biotech occupies a unique position in this landscape. Unlike mechanical or chemical approaches to carbon removal, biological processes operate at ambient temperature and pressure, self-replicate, and can generate co-products (biofuels, biomaterials, soil amendments, animal feed) that create revenue streams independent of carbon credit pricing. This multi-product economic model fundamentally changes the investability of carbon removal: whereas DAC facilities depend entirely on carbon credit or tax credit revenues to close their economics, biotech platforms can achieve profitability through product sales alone, with carbon removal credits providing margin expansion rather than sole revenue justification.

The strategic importance extends beyond carbon removal. Biological processes that fix atmospheric CO2 into durable materials displace fossil-derived feedstocks in chemicals, construction materials, textiles, and packaging. The global petrochemicals market, valued at $625 billion in 2024, represents the ultimate addressable market for bio-based alternatives that are both carbon-negative in production and functionally competitive in application. Founders building in this space are not merely creating carbon removal companies; they are building the biological manufacturing platforms that could restructure industrial supply chains.

Key Concepts

Engineered Microbial Carbon Fixation uses genetically modified or synthetically designed microorganisms to convert CO2 into target molecules with higher efficiency than natural biological systems. Researchers at the Max Planck Institute demonstrated synthetic CO2 fixation cycles (CETCH cycle) that operate 2-3 times faster than natural photosynthesis. Companies including LanzaTech and Cemvita Factory have engineered gas-fermenting bacteria that consume industrial waste gases (CO, CO2, H2) and produce ethanol, acetone, isopropanol, and other platform chemicals. The key economic variable is volumetric productivity: liters of product per liter of reactor volume per hour. Best-in-class fermentation systems achieve 3-5 g/L/hr for commodity molecules, compared to 0.5-1.5 g/L/hr for more complex target products.

Biomineralization and Enhanced Weathering accelerate natural geological processes that convert CO2 into stable carbonate minerals. Certain bacteria (ureolytic and carbonic anhydrase-producing strains) catalyze mineral carbonation at rates 100-1,000 times faster than abiotic weathering. Heirloom Carbon Technologies uses calcium oxide cycling with biological catalysts to capture CO2 from ambient air and store it as calcium carbonate, achieving verified removal at $200-400 per ton with a pathway to below $100. The permanence advantage is significant: mineralized carbon remains sequestered for 10,000+ years, compared to 100-year crediting periods typical for biological soil carbon or forestry projects.

Algal and Cyanobacterial Platforms harness photosynthetic microorganisms that grow 10-50 times faster than terrestrial plants and can be cultivated on non-arable land using saline or wastewater. Microalgae fix approximately 1.8 kg of CO2 per kg of biomass produced. The resulting biomass serves as feedstock for biofuels, animal feed, bioplastics, fertilizers, and specialty chemicals. Pond Technologies and Brilliant Planet have demonstrated open-pond cultivation systems in desert environments at scales exceeding 30 hectares, achieving biomass productivity of 20-30 g/m2/day. The primary economic challenge is dewatering and downstream processing, which can consume 30-50% of total production costs.

Biochar and Pyrolysis convert agricultural residues, forestry waste, or purpose-grown biomass into stable carbon-rich solids through thermal decomposition in oxygen-limited environments. Biochar sequesters 50-80% of the carbon in feedstock biomass for centuries to millennia while simultaneously improving soil water retention, nutrient cycling, and microbial activity. Pacific Biochar and Carbofex operate commercial-scale pyrolysis facilities producing 1,000-5,000 tons of biochar annually. Carbon credit revenues ($100-200 per ton of CO2 equivalent) combined with agricultural product sales ($300-800 per ton of biochar) create dual revenue streams that make the economics compelling at current scale.

Climate Biotech Value Pool Map: Revenue by Segment

Value Pool	2024 Revenue	2026E Revenue	2030E Revenue	Margin Profile
Gas Fermentation (chemicals)	$180M	$450M	$2.5B	25-35% gross
Biochar Production + Credits	$120M	$310M	$1.8B	30-45% gross
Algal Biomass Products	$95M	$220M	$1.2B	15-25% gross
Biomineralization Credits	$15M	$85M	$800M	40-55% gross
Synthetic Biology Platforms	$60M	$180M	$1.5B	50-70% gross
Engineered Soil Carbon	$40M	$130M	$700M	20-35% gross

What's Working

Gas Fermentation at Commercial Scale

LanzaTech represents the most advanced commercialization pathway in climate biotech. Their proprietary gas-fermenting bacteria convert CO2-rich industrial waste gases into ethanol and chemical intermediates at three commercial-scale facilities in China, India, and Belgium. The Shougang Steel facility in Beijing processes 80,000 tons of steel mill off-gas annually, producing 46,000 tons of ethanol. In 2025, LanzaTech commissioned its first facility using captured CO2 (rather than waste gas) as feedstock, in partnership with Brookfield Renewable, achieving production costs within 15% of fossil-derived ethanol. The company's licensing model generates high-margin technology fees while partners bear capital expenditure risk, a platform business model that other climate biotech founders should study carefully.

Biochar's Dual Revenue Model

The biochar sector has achieved commercial viability faster than most carbon removal pathways because it generates revenue from both product sales and carbon credits simultaneously. Carbofex's facility in Finland produces European Biochar Certificate-verified biochar that sells for EUR 500-800 per ton as a soil amendment while generating Puro.earth carbon removal credits at EUR 130-180 per ton of CO2 equivalent. The combined revenue of EUR 650-1,000 per ton of biochar against production costs of EUR 200-350 per ton delivers gross margins exceeding 45%. Feedstock optionality (agricultural residues, forestry waste, sewage sludge) provides supply chain resilience that single-feedstock biological processes lack.

Frontier Procurement Catalyzing Scale

The Frontier advance market commitment has proven transformative for climate biotech startups seeking to bridge the gap between pilot and commercial scale. In 2025, Frontier contracted $58 million in future carbon removal purchases from biological pathway companies including Charm Industrial (bio-oil sequestration), Running Tide (ocean biomass sinking), and Graphyte (biomass carbon removal and storage). These pre-purchase commitments, structured as binding offtake agreements at specified prices, provide the revenue certainty that project finance lenders require to underwrite construction debt. The model is replicating: the US Department of Energy's Carbon Dioxide Removal Purchase Pilot committed $35 million in 2025 to similar early-stage biological removal projects.

What's Not Working

Scale-up Mortality in Fermentation

The biotech industry's persistent challenge remains translating laboratory results to commercial-scale production. A 2025 analysis by Synonym Bio found that 65% of climate biotech startups that achieved promising bench-scale results (1-10 liter reactors) failed to maintain performance at pilot scale (1,000-10,000 liters). Common failure modes include contamination in non-sterile processes, heat transfer limitations that alter metabolic pathways, and shear stress from impeller mixing that damages cell viability. The capital requirements for scale-up are punishing: a single commercial-scale fermentation facility requires $50-200 million in capital expenditure, with 18-36 month construction timelines before first revenue. This "valley of death" between seed-stage proof-of-concept and commercial operation remains the primary filter separating winners from casualties.

MRV Complexity for Biological Systems

Measuring, reporting, and verifying carbon removal from biological processes is inherently more complex than for engineered systems. DAC facilities measure CO2 removal through simple mass balance: gas in, gas out. Biological systems involve dynamic, distributed carbon flows through organisms, soils, water, and atmosphere that resist simple accounting. The science of soil carbon measurement, for example, remains contested: sampling protocols, baseline establishment, and leakage accounting generate methodological debates that delay credit issuance and create buyer uncertainty. Isometric's 2025 registry analysis found that biological carbon removal credits took an average of 14 months from project completion to credit issuance, compared to 4 months for engineered removal, directly impacting project cash flows.

Feedstock Competition and Land Use Concerns

As climate biotech scales, competition for biological feedstock intensifies. Agricultural residues that biochar producers depend on are also demanded by cellulosic biofuel producers, animal bedding suppliers, and soil management programs. Purpose-grown biomass crops raise concerns about indirect land use change, food security trade-offs, and biodiversity impacts. A 2025 World Resources Institute analysis cautioned that scaling biomass-based carbon removal to 2 gigatons per year could require 300-500 million hectares of land, equivalent to 20-35% of current global cropland. Founders building biomass-dependent businesses must secure long-term feedstock contracts and demonstrate that their supply chains avoid displacement of food production or native ecosystems.

Key Players

Established Leaders

LanzaTech operates three commercial-scale gas fermentation facilities, has licensed its technology to 12 additional projects globally, and achieved $90 million in 2024 revenue. Their CarbonSmart platform enables brands to trace recycled-carbon content through supply chains.

Charm Industrial converts agricultural waste biomass into bio-oil, then injects it into deep geological formations for permanent sequestration. They have delivered over 10,000 tons of verified carbon removal to Frontier, Microsoft, and JPMorgan Chase.

Heirloom Carbon Technologies combines mineral carbonation with biological catalysts for direct air capture, operating a commercial facility in Tracy, California, with contracted removal volumes for Microsoft and the US government.

Emerging Startups

Cemvita Factory engineers CO2-utilizing bacteria to produce hydrogen, chemicals, and fuels from captured carbon. Their partnership with Oxy Low Carbon Ventures targets integration with Occidental's DAC infrastructure.

Brilliant Planet cultivates native microalgae in open desert ponds at scale, demonstrating 30-hectare systems in Morocco that achieve carbon fixation costs projected at $50-75 per ton at full scale.

Graphyte developed biomass carbon removal and storage (BiCRS), compressing dried biomass into blocks for geological storage, achieving Frontier-verified removal at $100 per ton.

Key Investors and Funders

Breakthrough Energy Ventures has invested over $500 million in climate biotech companies including LanzaTech, Heirloom, and Cemvita, with a focus on pathways achieving sub-$100 per ton removal costs.

Lowercarbon Capital has deployed capital across 30+ carbon removal startups, with particular emphasis on biological approaches offering near-term commercialization pathways.

ARPA-E has funded transformative biological carbon fixation research through programs including ECOSynBio and SMARTFARM, providing $200 million+ in non-dilutive grants.

Action Checklist

• Map your target molecule or product against competing fossil-derived alternatives to establish cost parity benchmarks
• Secure binding feedstock supply agreements for 5+ years before committing to commercial facility design
• Engage carbon credit registries (Puro.earth, Isometric, Verra) early to understand MRV requirements and crediting timelines
• Structure financing to include advance market commitment offtakes from corporate buyers (Frontier model) alongside traditional equity and project debt
• Design multi-product revenue models that achieve breakeven on product sales alone, treating carbon credits as margin upside
• Invest in scale-up de-risking through intermediate pilot stages (100-1,000 liter) before committing to commercial-scale capital expenditure
• Build partnerships with industrial off-takers who can provide waste gas or CO2 feedstock at low or negative cost
• Monitor regulatory developments in the EU CBAM, California cap-and-trade, and 45Q tax credit programs for demand signals

FAQ

Q: What is the most commercially viable climate biotech pathway in 2026? A: Gas fermentation and biochar production are the most commercially mature pathways, with multiple companies generating revenue at or near profitability. Gas fermentation benefits from established industrial infrastructure (steel mills, refineries providing feedstock) and large addressable markets for chemical products. Biochar benefits from the dual revenue model of product sales plus carbon credits. Biomineralization offers the highest long-term margin potential but remains earlier stage. Founders should evaluate pathways based on time-to-revenue, capital intensity, and feedstock security rather than theoretical carbon removal potential alone.

Q: How do carbon removal credits from biological processes compare in price to engineered removal? A: Biological carbon removal credits typically trade at $80-200 per ton of CO2, compared to $400-800 for DAC-based credits. The discount reflects shorter permanence guarantees (100-1,000 years versus 10,000+ years for mineralization) and higher MRV complexity. However, biological credits with strong permanence characteristics (biochar with 1,000+ year stability, bio-oil geological injection) are narrowing this gap, trading at $100-250 per ton. As MRV methodologies mature and registries build track records, the permanence discount for high-quality biological credits is expected to compress.

Q: What regulatory tailwinds should founders in this space monitor? A: The three most significant regulatory drivers are: (1) Section 45Q of the US Internal Revenue Code, providing $180 per ton tax credits for direct air capture and $85 per ton for point-source capture with geological storage; (2) the EU CBAM, which increases the cost of carbon-intensive imports and creates demand for carbon-negative manufacturing processes; and (3) state-level clean fuel standards (California, Oregon, Washington) that assign credits to fuels produced from captured CO2. Additionally, the USDA's Climate-Smart Commodities program has deployed $3.1 billion for agricultural carbon removal projects, directly funding biochar and soil carbon initiatives.

Q: What separates climate biotech companies that scale from those that fail? A: Three factors consistently differentiate successful scale-ups. First, multi-product revenue models that do not depend solely on carbon credit pricing. Second, demonstrated performance at intermediate pilot scale (1,000-10,000 liters for fermentation, 5+ hectares for algal cultivation) before raising growth-stage capital. Third, feedstock strategies that avoid competition with food production and secure supply through waste stream partnerships or purpose-grown crops on marginal land. Companies that achieve technical milestones without addressing commercial fundamentals, particularly unit economics at scale, feedstock security, and offtake agreements, consistently fail at the pilot-to-commercial transition.

Q: How large could the climate biotech market become by 2030? A: Aggregate revenue across climate biotech segments (gas fermentation chemicals, biochar, algal products, biomineralization credits, and synthetic biology platforms) could reach $8-12 billion by 2030, growing from approximately $500 million in 2024. The carbon removal credit component alone could reach $2-3 billion annually if removal volumes scale to 50-100 million tons per year at average prices of $50-100 per ton. The larger opportunity lies in bio-based chemical and material displacement of fossil-derived products, where the addressable market exceeds $100 billion.

Sources

• National Academies of Sciences, Engineering, and Medicine. (2025). Carbon Dioxide Removal: Progress and Prospects. Washington, DC: The National Academies Press.
• Intergovernmental Panel on Climate Change. (2023). AR6 Synthesis Report: Climate Change 2023. Geneva: IPCC.
• BloombergNEF. (2025). Carbon Removal Market Outlook 2025. New York: Bloomberg LP.
• Frontier. (2025). 2025 Carbon Removal Purchases: Portfolio Analysis. Available at: https://frontierclimate.com
• Synonym Bio. (2025). The State of Biomanufacturing Infrastructure. New York: Synonym.
• World Resources Institute. (2025). Land Use Implications of Biomass-Based Carbon Removal at Scale. Washington, DC: WRI.
• US Department of Energy. (2025). Carbon Negative Shot: Technology Pathways and Cost Trajectories. Washington, DC: DOE Office of Fossil Energy and Carbon Management.